Lucas Attia

Lucas is a machine learning scientist at Eli Lilly, where he develops small molecule property prediction and generation models for the Lilly TuneLab platform. He completed his Ph.D. in chemical engineering at MIT in April 2026, leveraging soft materials to process solubility-enhancing drug nanoparticles for his thesis work. He is passionate about developing computational tools for drug discovery and formulation. Lucas finds himself irresistibly drawn to the art of storytelling, whether it’s crafting a compelling research story that can engage generalist audiences or mourning the tragedies of his favorite professional sports teams.